# Contact Freebase Peptides — Editorial Desk

> Reach the Freebase Peptides editorial desk regarding citations, corrections, or research-related correspondence about our Metabolic & Weight Research peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a reference desk most wants to hear about.

## Editorial correspondence

Freebase Peptides welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about retatrutide, MOTS-c, or tesamorelin that should be added to the [references page](/references). Corrections that improve the accuracy of the digest are the most useful messages we receive.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source quickly.

**Editorial mailbox:** editors@freebasepeptides.com

## What this desk cannot do

A few things fall outside what this site can address. Freebase Peptides is a literature digest, not a clinic or a vendor, so we cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or judge whether a particular research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Answer requests from athletes subject to anti-doping rules about using these compounds, given that several are prohibited in sport.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

A clinical briefing on metabolic research peptides — peer-reviewed citations, stated approval status, no doses and no products.